CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
676-690 of 964
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
CME/CEThe Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
MinuteCE®ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
ns-MRAs and eGFR Slope: The Kidney Perspective
MinuteCE®ns-MRAs and eGFR Slope: The Kidney Perspective
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
CME/CE Broadcast ReplayOptimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
CME/CEThe Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
- advertisement
Advances in the Treatment and Management of MASH: More Options, More Decisions
CME/CE Broadcast ReplayAdvances in the Treatment and Management of MASH: More Options, More Decisions
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
CME/CE Broadcast ReplayDifferentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
MinuteCE®Application of guidelines-recommended broad molecular profiling to patients with NSCLC
Clinical evidence driving guidelines for immunotherapy in the neoadjuvant and adjuvant settings of NSCLC
MinuteCE®Clinical evidence driving guidelines for immunotherapy in the neoadjuvant and adjuvant settings of NSCLC
Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
MinuteCE®Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
- advertisement
Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC
MinuteCE®Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC
Guideline recommendations for first-line treatment of advanced NSCLC with targeted therapies
MinuteCE®Guideline recommendations for first-line treatment of advanced NSCLC with targeted therapies
Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC
MinuteCE®Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC
